Surveillance of Adverse Events After Vaccination in Poor Settings
Author Information
Author(s): Breugelmans Gabrielle J, Gessner Bradford
Primary Institution: Agence de Medecine Preventive, c/o Institut Pasteur, 75724 Paris Cedex 15, France
Hypothesis
Vaccine safety profiles cannot be generalized to developing countries due to local influences.
Conclusion
There is an urgent need for effective surveillance of serious adverse events following immunization in resource-poor settings.
Supporting Evidence
- Vaccine safety is evaluated through various studies and surveillance.
- Low-income countries often lack the resources for effective vaccine safety monitoring.
- The introduction of new vaccines in sub-Saharan Africa increases the need for safety surveillance.
Takeaway
Vaccines are important for health, but we need to make sure they are safe, especially in poorer countries where things can be different.
Methodology
The study discusses the need for functional pharmacovigilance systems and the development of surveillance tools for monitoring vaccine safety.
Limitations
Few low-income economies have functional national pharmacovigilance systems due to lack of resources.
Want to read the original?
Access the complete publication on the publisher's website